Search - tctmd.com

Displaying 301 - 320 of 699

Sort: Relevancy | Date

Presentation TCT 2018

2018 European Guidelines and Perspectives on Hypertension

Presenter: Vasilios Papademetriou, Paul A. Sobotka, Adam Witkowski

September 24, 2018

Presentation TCT 2018

Hypertension 2018 Update: From Ambulatory Monitoring to Definitional Controversies and More

Presenter: Vasilios Papademetriou, Paul A. Sobotka, Michael A. Weber

September 24, 2018

Presentation TCT 2018

REDUCE HTN: REINFORCE: A Sham-Controlled, Off-Med Randomized Trial of Renal Denervation for Treatment of Hypertension

Presenter: John A. Bittl, Bernard J. Gersh, Michael A. Weber

September 24, 2018

Presentation TCT 2018

Chimneys, Snorkels, and Periscopes for the Treatment of Juxta-Renal Abdominal Aortic Aneurysms: Are There Any Data to Support Them?

Presenter: Robert A. Lookstein, Virendra I Patel

September 23, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

Presentation TCT 2018

Thailand Presents: Percutaneous Closure of a High-Flow Acquired Renal AV Fistula Using AVP2 in a Patient With Heart Failure and Pulmonary Hypertension

Presenter: Yutaka Hikichi, Teguh Santoso, Hsuan-Li Huang, Wirash Kehasukcharoen, Wen-Lieng Lee, Samuel Sudanawidjaja, Damras Tresukosol

September 23, 2018

Presentation TCT 2018

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Hiren Mistry

September 22, 2018

Presentation TCT 2018

Japanese Perspective and Experience on RDN Studies

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno

September 22, 2018

Presentation TCT 2018

Renal Vein Pressure Decompression for ADHF: Magenta

Presenter: William T. Abraham, JoAnn Lindenfeld, David D Israeli

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Presentation TCT 2018

TCT-31: Comparison of Standard Renal Denervation Procedure versus Novel Distal and Branch Vessel Procedure with Brachial Arterial Access

Presenter: Melvin D. Lobo, Ivo Petrov

September 21, 2018

Presentation TCT 2018

TCT-30: Renal Denervation Improves Cardiac Function in a Swine Model of Heart Failure

Presenter: Melvin D. Lobo, Ivo Petrov, Traci Goodchild

September 21, 2018

Presentation TCT 2018

TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation

Presenter: Melvin D. Lobo, Ivo Petrov, Ajay J. Kirtane

September 21, 2018

Presentation TCT 2018

ISR and Complex Anatomy in Renal Stenting

Presenter: Sahil A. Parikh, Virendra I Patel, Mark C. Bates

September 21, 2018

Presentation TCT 2018

Optimal Renal Stenting Technique

Presenter: Sahil A. Parikh, Virendra I Patel

September 21, 2018

Presentation TCT 2018

Renal Artery Interventions After ASTRAL and CORAL: Who Should We Treat?

Presenter: Sahil A. Parikh, Virendra I Patel, Kenneth Rosenfield

September 21, 2018

Presentation TCT 2018

Renal Denervation: Light on the Horizon?

Presenter: Jeroen J. Bax, Stephan Windecker, Felix Mahfoud

September 21, 2018

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Imaging and physiology-guided PCI without contrast administration in advanced renal failure

Presenter: Ziad A. Ali

May 06, 2018

Presentation Controversies and Advances 2017

Rise, Fall And Resurrection of Renal Denervation

Presenter: Michael A. Weber

November 16, 2017

Advertisement

2018 European Guidelines and Perspectives on Hypertension

Hypertension 2018 Update: From Ambulatory Monitoring to Definitional Controversies and More

REDUCE HTN: REINFORCE: A Sham-Controlled, Off-Med Randomized Trial of Renal Denervation for Treatment of Hypertension

Chimneys, Snorkels, and Periscopes for the Treatment of Juxta-Renal Abdominal Aortic Aneurysms: Are There Any Data to Support Them?

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Thailand Presents: Percutaneous Closure of a High-Flow Acquired Renal AV Fistula Using AVP2 in a Patient With Heart Failure and Pulmonary Hypertension

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Japanese Perspective and Experience on RDN Studies

Renal Vein Pressure Decompression for ADHF: Magenta

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

TCT-31: Comparison of Standard Renal Denervation Procedure versus Novel Distal and Branch Vessel Procedure with Brachial Arterial Access

TCT-30: Renal Denervation Improves Cardiac Function in a Swine Model of Heart Failure

TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation

ISR and Complex Anatomy in Renal Stenting

Optimal Renal Stenting Technique

Renal Artery Interventions After ASTRAL and CORAL: Who Should We Treat?

Renal Denervation: Light on the Horizon?

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Imaging and physiology-guided PCI without contrast administration in advanced renal failure

Rise, Fall And Resurrection of Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content